New heart mapping tech aims to better target irregular heartbeat treatment

NCT ID NCT06529978

Recruiting now Disease control Sponsor: CoreMap Inc. Source: ClinicalTrials.gov ↗

Summary

This study is testing a new heart mapping system designed to help doctors better target treatment for persistent atrial fibrillation (AFib), a common irregular heartbeat. The research will see if using this detailed map to guide a standard ablation procedure is safe and more effective at keeping the heart's normal rhythm. It aims to enroll 245 adults with persistent AFib who have not had prior ablation treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERSISTENT ATRIAL FIBRILLATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Email: •••••@•••••

Locations

NCH Downtown Baker Hospital
ENROLLING_BY_INVITATION

Naples, Florida, 34102, United States
Na Homolce Hospital
RECRUITING

Praha Klanovice, Czechia
University of Vermont Medical Center
ENROLLING_BY_INVITATION

Burlington, Vermont, 05401, United States

Conditions

Explore the condition pages connected to this study.

PERSISTENT ATRIAL FIBRILLATION